Thromboembolic and major bleeding events in relation to perioperative bridging of vitamin K antagonists in 649 fast-track total hip and knee arthroplasties.

Comparative efficacy and safety of anticoagulants for prevention of venous thromboembolism after hip and knee arthroplasty. Acta Orthop (2017) 0.75

Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98

The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull (1999) 14.29

Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest (2009) 14.06

Perioperative Bridging Anticoagulation in Patients with Atrial Fibrillation. N Engl J Med (2015) 10.86

Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med (2009) 8.25

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

Perioperative management of antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.29

Periprocedural heparin bridging in patients receiving vitamin K antagonists: systematic review and meta-analysis of bleeding and thromboembolic rates. Circulation (2012) 3.74

2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J (2014) 2.10

Administrative database research infrequently used validated diagnostic or procedural codes. J Clin Epidemiol (2011) 1.94

Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol (2010) 1.93

Existing data sources for clinical epidemiology: The Danish National Database of Reimbursed Prescriptions. Clin Epidemiol (2012) 1.77

Pro: "Bridging anticoagulation is needed during warfarin interruption in patients who require elective surgery". Thromb Haemost (2012) 1.65

Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures. JAMA Intern Med (2015) 1.54

Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost (2009) 1.45

Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop (2010) 1.44

Fast-track hip and knee arthroplasty. Lancet (2013) 1.27

Care principles at four fast-track arthroplasty departments in Denmark. Dan Med Bull (2010) 1.26

Bridging therapy in patients on long-term oral anticoagulants who require surgery: the Prospective Peri-operative Enoxaparin Cohort Trial (PROSPECT). J Thromb Haemost (2007) 1.23

Perioperative bridging anticoagulation during dabigatran or warfarin interruption among patients who had an elective surgery or procedure. Substudy of the RE-LY trial. Thromb Haemost (2014) 1.22

Role of patient characteristics for fast-track hip and knee arthroplasty. Br J Anaesth (2013) 1.17

Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Circulation (2009) 1.07

Thromboprophylaxis only during hospitalisation in fast-track hip and knee arthroplasty, a prospective cohort study. BMJ Open (2013) 1.02

Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures. Acta Orthop (2013) 1.02

Periprocedural antithrombotic and bridging therapy: recommendations for standardized reporting in patients with arterial indications for chronic oral anticoagulant therapy. J Thromb Haemost (2012) 1.01

Complications related to therapeutic anticoagulation in total hip arthroplasty. J Arthroplasty (2013) 0.86

Peri-procedural management of patients taking oral anticoagulants. BMJ (2015) 0.84

Early thromboembolic events ≤1week after fast-track total hip and knee arthroplasty. Thromb Res (2015) 0.80

High complication rate after total knee and hip replacement due to perioperative bridging of anticoagulant therapy based on the 2012 ACCP guideline. Arch Orthop Trauma Surg (2014) 0.79

Contra: "Bridging anticoagulation is needed during warfarin interruption when patients require elective surgery". Thromb Haemost (2012) 0.77

Bridging therapy for oral anticoagulation increases the risk for bleeding-related complications in total joint arthroplasty. J Orthop Surg Res (2015) 0.77

Perioperative complications in patients on low-molecular-weight heparin bridging therapy. ANZ J Surg (2013) 0.77

Perioperative Heparin Bridging in Atrial Fibrillation Patients Requiring Temporary Interruption of Anticoagulation: Evidence from Meta-analysis. J Stroke Cerebrovasc Dis (2016) 0.77